The titles below are reviews that have been published but now require a new team for future updates.
Cochrane Skin is currently undertaking a prioritisation project involving external stakeholders, in which we are assessing our entire portfolio of titles (registered and published).We will not be accepting applications for vacant titles or reviews until we know the results of the project.
- Treatments for diaper/nappy dermatitis
- Dietary exclusions for established atopic eczema
(1 original co-author wishes to remain on any new team that is formed, and 4 individuals have expressed interest in this title*. Please also note that 1) most of the data abstraction for this review is already available on the GREAT database, and 2) the future team on this review update must 'exclude' the mothers included in the following Cochrane review: Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD000133. DOI: 10.1002/14651858.CD000133.pub3)
- Topical pimecrolimus for eczema
(3 individuals have expressed interest in this title*. Topical pimecrolimus prevents flare-ups of eczema. The update should contain a summary of the evaluation of proactive and reactive therapy to prevent flare-ups, as well as short-term controls)
- Topical treatments for cutaneous warts - JOINT 3RD MOST CITED SKIN GROUP REVIEW IN 2014
(Please note that this is a very large review (last assessed as up-to-date: 11th May 2011; number of included studies: 85), so it would need a very competent team experienced in Cochrane methodology to apply for it)
- Lasers or light sources for treating port-wine stains
(1 individual has expressed interest in this title*)
- Dietary supplements for established atopic eczema - JOINT 4TH MOST CITED SKIN GROUP REVIEW IN 2014
(2 original co-authors wish to remain on any new team that's formed*)
- Topical treatments for chronic plaque psoriasis
(1 original author wishes to remain on any new team that's formed*)
- Minocycline for acne vulgaris: efficacy and safety
(3 original co-authors wish to remain on any new team that's formed*. Please note that because of the profile of minocycline, there will need to be a discussion of adverse effects, which increases the workload for this review.)
*Please contact the editorial base for the details of these individuals.